{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:44:43Z","timestamp":1791409483959,"version":"4.3.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT 1064841"],"award-info":[{"award-number":["GNT 1064841"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1158646"],"award-info":[{"award-number":["GNT1158646"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.11.006","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T02:31:55Z","timestamp":1668565915000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3341-7964","authenticated-orcid":false,"given":"Nusrat","family":"Homaira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Strachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Beggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mejbah","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K","family":"Fawcett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn L","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Macartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C","family":"Martin MD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"McCallum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"McCullagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiran","family":"Selvadurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Oftadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarath","family":"Ranganathan PhD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadasivam","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Snelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2022.11.006_b0005","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2471\/BLT.07.048769","article-title":"Epidemiology and etiology of childhood pneumonia","volume":"86","author":"Rudan","year":"2008","journal-title":"Bull World Health Organ"},{"issue":"9875","key":"10.1016\/j.vaccine.2022.11.006_b0010","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(13)60222-6","article-title":"Global burden of childhood pneumonia and diarrhoea","volume":"381","author":"Walker","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.006_b0015","first-page":"e00937","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"J MBio"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.006_b0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5694\/j.1326-5377.2011.tb04192.x","article-title":"Changing epidemiology of invasive pneumococcal disease in Australian children after introduction of a 7-valent pneumococcal conjugate vaccine","volume":"194","author":"Williams","year":"2011","journal-title":"Med J Aust"},{"issue":"11","key":"10.1016\/j.vaccine.2022.11.006_b0025","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/INF.0b013e31817e5188","article-title":"Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine","volume":"27","author":"Hendrickson","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2022.11.006_b0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/thoraxjnl-2020-216032","article-title":"Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia","volume":"76","author":"Strachan","year":"2021","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.006_b0035","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1542\/peds.2013-3181","article-title":"Duration of protection after first dose of acellular pertussis vaccine in infants","volume":"133","author":"Quinn","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.11.006_b0040","unstructured":"Australian Bureau of Statistics. Socio-Economic Indexes for Areas (SEIFA) 2016. Canberra; 2018. Contract No.: Report No.: Cat. No. 2033.0.55.001."},{"key":"10.1016\/j.vaccine.2022.11.006_b0045","series-title":"The WHO manual of diagnostic imaging: radiographic anatomy and interpretation of the chest and the pulmonary system","author":"Ellis","year":"2006"},{"issue":"10","key":"10.1016\/j.vaccine.2022.11.006_b0050","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3201\/eid1710.101825","article-title":"Bacterial causes of empyema in children, Australia, 2007\u20132009","volume":"17","author":"Strachan","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.006_b0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1099\/jmm.0.45924-0","article-title":"A molecular-capsular-type prediction system for 90 Streptococcus pneumoniae serotypes using partial cpsA-cpsB sequencing and wzy- or wzx-specific PCR","volume":"54","author":"Kong","year":"2005","journal-title":"J Med Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.006_b0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2022.11.006_b0065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.006_b0070","doi-asserted-by":"crossref","unstructured":"Lodi L, Ricci S, Nieddu F, et al. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Severe Invasive Disease Caused by Serotype 3 Streptococcus Pneumoniae in Italian Children. Vaccines (Basel). Sep 24 2019;7(4)doi:10.3390\/vaccines7040128.","DOI":"10.3390\/vaccines7040128"},{"issue":"5","key":"10.1016\/j.vaccine.2022.11.006_b0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ppul.24279","article-title":"Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era","volume":"54","author":"Diaz-Conradi","year":"2019","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.006_b0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/archdischild-2014-306525","article-title":"Has the incidence of empyema in Scottish children continued to increase beyond 2005?","volume":"100","author":"Nath","year":"2015","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.vaccine.2022.11.006_b0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/23744235.2016.1192720","article-title":"Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine","volume":"48","author":"Syrogiannopoulos","year":"2016","journal-title":"Infectious Diseases"},{"key":"10.1016\/j.vaccine.2022.11.006_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.613287","article-title":"Sugar-coated killer: Serotype 3 pneumococcal disease","volume":"10","author":"Luck","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.006_b0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/INF.0b013e318247ef84","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media","volume":"31","author":"Cohen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.006_b0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/ciy129","article-title":"Effectiveness of 7-and 13-valent pneumococcal conjugate vaccines in a schedule without a booster dose: a 10-year observational study","volume":"67","author":"Jayasinghe","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.006_b0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1086\/518438","article-title":"Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial","volume":"196","author":"O'Brien","year":"2007","journal-title":"J Infect Dis"},{"issue":"9546","key":"10.1016\/j.vaccine.2022.11.006_b0110","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2022.11.006_b0115","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.11.006_b0120","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1469-0691.2006.1502_1.x","article-title":"Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine","volume":"12","author":"Calbo","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.006_b0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1469-0691.2006.01646.x","article-title":"Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine","volume":"13","author":"Obando","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.006_b0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1086\/338460","article-title":"An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations","volume":"34","author":"Byington","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.006_b0135","doi-asserted-by":"crossref","unstructured":"Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. Mar 26-Apr 1 2005;365(9465):1139-46. doi:10.1016\/S0140-6736(05)71876-6.","DOI":"10.1016\/S0140-6736(05)71876-6"},{"issue":"10","key":"10.1016\/j.vaccine.2022.11.006_b0140","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3201\/eid1710.101825","article-title":"Bacterial causes of empyema in children, Australia, 2007\u20132009","volume":"17","author":"Strachan","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2022.11.006_b0145","first-page":"1361","article-title":"Persistent circulation of vaccine serotypes and serotype replacement after 5 years of infant immunization with 13-valent pneumococcal conjugate vaccine in the United Kingdom","volume":"221","author":"Kandasamy","year":"2020","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.006_b0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/vaccines9040305","article-title":"Pneumococcal disease prevention: are we on the right track?","volume":"9","author":"Principi","year":"2021","journal-title":"Vaccines"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2023.07.039","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22013822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22013822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:32:15Z","timestamp":1778679135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22013822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22013822"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}